0414 Results From an On-Road Driving Performance Study In Non-elderly And Elderly Healthy Subjects with Dual Orexin Receptor Antagonist Lemborexant

A. Vermeeren; E. Vuurman; S. Jongen; C. Van Leeuwen; A. Van Oers; J. Ramaekers; P. Murphy; M. Moline; C. Perdomo; K. Pinner

doi:10.1093/sleep/zsy061.413

0414 Results From an On-Road Driving Performance Study In Non-elderly And Elderly Healthy Subjects with Dual Orexin Receptor Antagonist Lemborexant

A. Vermeeren, E. Vuurman, S. Jongen, C. Van Leeuwen, A. Van Oers, J. Ramaekers, P. Murphy, M. Moline, C. Perdomo, K. Pinner

Research output: Contribution to journal › Conference Abstract/Poster in journal › Academic

Abstract

Sedating cns-active drugs are typically studied for the potential to impair next-morning driving. Data from an on-road driving performance study are presented for lemborexant (lem), a dual orexin receptor antagonist under development for insomnia disorder.

Original language	English
Pages (from-to)	A157
Number of pages	1
Journal	Sleep (Online)
Volume	41
Issue number	Suppl. 1
DOIs	https://doi.org/10.1093/sleep/zsy061.413
Publication status	Published - 27 Apr 2018
Event	32nd Annual Meeting of the Associated Professional Sleep Societies, LLC - Baltimore, United States Duration: 2 Jun 2018 → 6 Jun 2018

Access to Document

10.1093/sleep/zsy061.413

Cite this

@article{f6a90dbc3b0344b89ac6f4d7c27957d4,

title = "0414 Results From an On-Road Driving Performance Study In Non-elderly And Elderly Healthy Subjects with Dual Orexin Receptor Antagonist Lemborexant",

abstract = "Sedating cns-active drugs are typically studied for the potential to impair next-morning driving. Data from an on-road driving performance study are presented for lemborexant (lem), a dual orexin receptor antagonist under development for insomnia disorder.",

author = "A. Vermeeren and E. Vuurman and S. Jongen and {Van Leeuwen}, C. and {Van Oers}, A. and J. Ramaekers and P. Murphy and M. Moline and C. Perdomo and K. Pinner",

year = "2018",

month = apr,

day = "27",

doi = "10.1093/sleep/zsy061.413",

language = "English",

volume = "41",

pages = "A157",

journal = "Sleep (Online)",

issn = "1550-9109",

publisher = "Oxford University Press",

number = "Suppl. 1",

note = "32nd Annual Meeting of the Associated Professional Sleep Societies, LLC ; Conference date: 02-06-2018 Through 06-06-2018",

}

Vermeeren, A, Vuurman, E, Jongen, S , Van Leeuwen, C , Van Oers, A , Ramaekers, J, Murphy, P, Moline, M, Perdomo, C & Pinner, K 2018, '0414 Results From an On-Road Driving Performance Study In Non-elderly And Elderly Healthy Subjects with Dual Orexin Receptor Antagonist Lemborexant', Sleep (Online), vol. 41, no. Suppl. 1, pp. A157. https://doi.org/10.1093/sleep/zsy061.413

TY - JOUR

T1 - 0414 Results From an On-Road Driving Performance Study In Non-elderly And Elderly Healthy Subjects with Dual Orexin Receptor Antagonist Lemborexant

AU - Vermeeren, A.

AU - Vuurman, E.

AU - Jongen, S.

AU - Van Leeuwen, C.

AU - Van Oers, A.

AU - Ramaekers, J.

AU - Murphy, P.

AU - Moline, M.

AU - Perdomo, C.

AU - Pinner, K.

PY - 2018/4/27

Y1 - 2018/4/27

N2 - Sedating cns-active drugs are typically studied for the potential to impair next-morning driving. Data from an on-road driving performance study are presented for lemborexant (lem), a dual orexin receptor antagonist under development for insomnia disorder.

AB - Sedating cns-active drugs are typically studied for the potential to impair next-morning driving. Data from an on-road driving performance study are presented for lemborexant (lem), a dual orexin receptor antagonist under development for insomnia disorder.

U2 - 10.1093/sleep/zsy061.413

DO - 10.1093/sleep/zsy061.413

M3 - Conference Abstract/Poster in journal

SN - 1550-9109

VL - 41

SP - A157

JO - Sleep (Online)

JF - Sleep (Online)

IS - Suppl. 1

T2 - 32nd Annual Meeting of the Associated Professional Sleep Societies, LLC

Y2 - 2 June 2018 through 6 June 2018

ER -

0414 Results From an On-Road Driving Performance Study In Non-elderly And Elderly Healthy Subjects with Dual Orexin Receptor Antagonist Lemborexant

Abstract

Access to Document

Fingerprint

Cite this